首页> 外文会议>Annual meeting exposition of the Controlled Release Society >New Approach to Enhance the Performance of Oral Camptothecins. SP1060C-O – a NewHighly Active Block Copolymer-Topotecan Composition with Selective and SustainedAbsorption of the Drug Lactone Form
【24h】

New Approach to Enhance the Performance of Oral Camptothecins. SP1060C-O – a NewHighly Active Block Copolymer-Topotecan Composition with Selective and SustainedAbsorption of the Drug Lactone Form

机译:增强口服喜树碱性能的新方法。 SP1060C-O –一种新型高活性嵌段共聚物-拓扑替康组合物,具有选择性和持续吸收药物内酯的形式

获取原文

摘要

SP1010C-O is an oral formulation oftopotecan that has increased bioavailabilityof the active lactone drug form. SP1060C-Ohas been shown to be considerably moreactive than the parent marketed drugadministered by either intravenousinjection, or orally. Relatively to otherknown formulations of camptothecins,SP1060C-O provides the highest lactoneto-carboxilate ratio in plasma and tumordrug accumulation, which results insignificantly higher anticancer activity andwell tolerable toxicity as demonstrated inseveral relevant animal models.
机译:SP1010C-O是下列药物的口服制剂 生物利用度提高的拓扑替康 活性内酯药物形式。 SP1060C-O 已经显示出更多 比母体上市的药物活跃 静脉注射 注射或口服。相对于其他 喜树碱的已知配方, SP1060C-O可提供最高的内酯 血浆和肿瘤中的羧酸盐比率 药物蓄积,导致 明显更高的抗癌活性和 耐受性良好,如 几种相关的动物模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号